The DOI matches its Crossref record; 295 of the 295 references it cites were found in a registry or an index.
Oral delivery of anticancer drugs: Challenges and opportunities
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–295 of 295
Oral uptake and translocation of a polylysine dendrimer with a lipid surface
Florence, A. T., Sakthivel, T., & Tóth, I. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00237-0 · Cited by 108
Matrix metalloproteinase inhibitors
Ramnath, N., & Creaven, P. J. (2004) · Current Oncology Reports · doi:10.1007/s11912-004-0020-7 · Cited by 108
Aisha, A. F. A., Ismail, Z., Abu–Salah, K. M., & Majid, A. M. S. A. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22806 · Cited by 107
Narang, A. S., & Desai, D. S. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0131-6_2 · Cited by 106
Gore, M. E., Oza, A. M., Rustin, G. J. S., Malfetano, J. H., Calvert, H., Clarke‐Pearson, D. L., Carmichael, J., Ross, G. A., Beckman, R., & Fields, S. Z. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00188-5 · Cited by 106
Casadei, M. A., Cerreto, F., Cesa, S., Giannuzzo, M., Feeney, M. M. M., Marianecci, C., & Paolicelli, P. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.06.012 · Cited by 103
Polyethylene glycol-coated liposomes for oral delivery of recombinant human epidermal growth factor
Li, H. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00158-3 · Cited by 102
Tumor targeting by conjugation of DHA to paclitaxel
Bradley, M. O., Swindell, C. S., Anthony, F. H., Witman, P. A., Devanesan, P. D., Webb, N. L., Baker, S. D., Wolff, A. C., & Donehower, R. C. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00321-2 · Cited by 101
Oral microemulsions of paclitaxel: In situ and pharmacokinetic studies
Nornoo, A. O., Zheng, H., Lopes, L. B., et al. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.015 · Cited by 100
Potential Oral Delivery of 7-Ethyl-10-Hydroxy-Camptothecin (SN-38) using Poly(amidoamine) Dendrimers
Kolhatkar, R. B., Swaan, P. W., & Ghandehari, H. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9572-9 · Cited by 100
Langoth, N., Kahlbacher, H., Schöffmann, G., Schmerold, I., Schuh, M., Franz, S., Kurka, P., & Bernkop‐Schnürch, A. (2006) · Pharmaceutical Research · doi:10.1007/s11095-005-9533-5 · Cited by 98
Enhanced Oromucosal Delivery of Progesterone Via Hexosomes
Swarnakar, N. K., Jain, V. K., Dubey, V., Mishra, D. K., & Jain, N. K. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9409-y · Cited by 98
Gürsoy, R. N., Garrigue, J., Razafindratsita, A., Lambert, G., Benita, S., & Bloom, D. R. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10501 · Cited by 97
Lv, P., Wei, W., Yue, H., Yang, T., Wang, L.-Y., & Ma, G. (2011) · Biomacromolecules · doi:10.1021/bm2010774 · Cited by 97
Jeong, Y., & Kang, D. H. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s19491 · Cited by 96
Wang, C., Ho, P. C., & Lim, L. Y. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.08.023 · Cited by 96
Bypassing Multidrug Resistance in Cancer Cells with Biodegradable Polymer Capsules
Yan, Y., Ochs, C. J., Such, G. K., Heath, J. K., Nice, E. C., & Caruso, F. (2010) · Advanced Materials · doi:10.1002/adma.201003162 · Cited by 94
Lectin anchored PLGA nanoparticles for oral mucosal immunization against hepatitis B
Mishra, N., Tiwari, S., Vaidya, B., Agrawal, G. P., & Vyas, S. P. (2011) · Journal of Drug Targeting · doi:10.3109/10611861003733946 · Cited by 94
Pharmaceutical Perspectives of Cancer Therapeutics
Lu, Y. W., & Mahato, R. I. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0131-6 · Cited by 93
Sweet, D., Kolhatkar, R. B., Ray, A., Swaan, P. W., & Ghandehari, H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.04.022 · Cited by 93
Ling, S. S. N., Magosso, E., Khan, N. A. K., Yuen, K. H., & Barker, S. A. (2006) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040500519102 · Cited by 93
Jain, A. K., Swarnakar, N. K., Das, M., Godugu, C., Singh, R. P., Rao, P. R., & Jain, S. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200011f · Cited by 89
Self-citationEffect of Block Size and Sequence on the Micellization of ABC Triblock Methacrylic Polyampholytes
Chen, W.-Y., Alexandridis, P., Su, C.-K., Patrickios, C. S., Hertler, W. R., & Hatton, T. A. (1995) · Macromolecules · doi:10.1021/ma00129a020 · Cited by 89
Anticancer carrier-linked prodrugs in clinical trials
Kratz, F., Ajaj, K. A., & Warnecke, A. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.7.1037 · Cited by 88
Struck, R. F., Alberts, D. S., Horne, K., Phillips, J. G., Peng, Y., & Roe, D. J. (1987) · PubMed · Cited by 88
Paixão, P. J. P. A., Gouveia, L. F., & Morais, J. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.03.019 · Cited by 87
Oral bioavailability of docetaxel in combination with OC144-093 (ONT-093)
Kuppens, I. E. L. M., Bosch, T. M., van Maanen, M. J., Rosing, H., Fitzpatrick, A., Beijnen, J. H., & Schellens, J. H. M. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0864-4 · Cited by 87
Arima, H., Yunomae, K., Hirayama, F., et al. (2001) · PubMed · Cited by 85
Yunomae, K., Arima, H., Hirayama, F., & Uekama, K. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00059-0 · Cited by 84
Schulze, J. D. R., Waddington, W. A., Ell, P. J., Parsons, G. E., Coffin, M. D., & Basit, A. W. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000008046.64409.bd · Cited by 83
Chemically modified chitosans as enzyme inhibitors
Bernkop‐Schnürch, A., & Kast, C. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00196-x · Cited by 83
Li, H., Huo, M., Zhou, J., Dai, Y., Deng, Y., Shi, X., & Mohammad, J. M. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22159 · Cited by 81
Methotrexate Loaded Solid Lipid Nanoparticles (SLN) for Effective Treatment of Carcinoma
Kandasamy, R., Manickam, S., & Ganeshkumar, P. A. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.457 · Cited by 80
Chen, J., Zeng, Gao, Hu, Song, Xia, Liu, Gu, Pang, Z., Chen, et al. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s32599 · Cited by 80
Self-assembled nanoparticles of poly(lactide)–Vitamin E TPGS copolymers for oral chemotherapy
ZHANG, Z., & FENG, S. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.06.013 · Cited by 79
The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles
Samstein, R. M., Perica, K., Balderrama, F., Look, M., & Fahmy, T. M. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.10.026 · Cited by 79
Varma, M. V. S., & Panchagnula, R. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20309 · Cited by 78
Choi, J. S., & Jo, B.-W. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.05.014 · Cited by 77
In Vitro Evaluation of Polymerized Liposomes as an Oral Drug Delivery System
Okada, J., Cohen, S., & Langer, R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016214332030 · Cited by 75
Fraction of a dose absorbed estimation for structurally diverse low solubility compounds
Sugano, K. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.11.049 · Cited by 75
Iusuf, D., Teunissen, S. F., Wagenaar, E., Rosing, H., Beijnen, J. H., & Schinkel, A. H. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.178301 · Cited by 75
Grosse, P.-Y., Bressolle, F., & Pinguet, F. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.648 · Cited by 74
Kuan, C.-Y., Walker, T., Luo, P. G., & Chen, C. (2011) · Journal of the American College of Nutrition · doi:10.1080/07315724.2011.10719969 · Cited by 72
Oral Delivery of DMAB-Modified Docetaxel-Loaded PLGA-TPGS Nanoparticles for Cancer Chemotherapy
Chen, H., Zheng, Y., Tian, G., Tian, Y., Zeng, X., Liu, G., Liu, K., Li, L., Li, Z., Mei, L., et al. (2010) · Nanoscale Research Letters · doi:10.1007/s11671-010-9741-8 · Cited by 72
Controlled Synthesis of Camptothecin−Polylactide Conjugates and Nanoconjugates
Tong, R., & Cheng, J. (2009) · Bioconjugate Chemistry · doi:10.1021/bc900356g · Cited by 70
Li, X., Xu, Y., Chen, G., Wei, P., & Ping, Q. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040701484593 · Cited by 70
Bisht, S., Feldmann, G., Koorstra, J.-B. M., Mullendore, M. E., Alvarez, H., Karikari, C. A., Rudek, M. A., Lee, C. K., Maitra, A., & Maitra, A. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0476 · Cited by 68
Alternative oral exemestane formulation: Improved dissolution and permeation
Yavuz, B., Bilensoy, E., Vural, İ., & Şumnu, M. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.07.046 · Cited by 66
Pawar, Y. B., Purohit, H. S., Valicherla, G. R., Munjal, B., Lale, S. V., Patel, S., & Bansal, A. K. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.031 · Cited by 66
Jain, P., Jain, S., Jain, S., Prasad, K. N., Jain, S. K., Jain, S., & Vyas, S. P. (2009) · Molecular Pharmaceutics · doi:10.1021/mp8002539 · Cited by 65
Self-citationPandita, D., Pandita, D., Ahuja, A., Velpandian, T., Lather, V., Dutta, T., & Khar, R. K. (2009) · Die Pharmazie · doi:10.31083/ph.2009.8338 · Cited by 64
Shah, A. V., & Serajuddin, A. T. M. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0704-x · Cited by 63
Effects of ketoconazole and carbamazepine on lapatinib pharmacokinetics in healthy subjects
Smith, D. A., Koch, K. M., Arya, N., Bowen, C. J., Herendeen, J. M., & Beelen, A. P. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03370.x · Cited by 63
Permeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayers
Pisal, D. S., Yellepeddi, V., Kumar, A., Kaushik, R. S., Hildreth, M. B., Guan, X., & Palakurthi, S. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.08.033 · Cited by 59
Aqueous-Core Lipid Nanocapsules for Encapsulating Fragile Hydrophilic and/or Lipophilic Molecules
Anton, N., Saulnier, P., Gaillard, C., et al. (2009) · Langmuir · doi:10.1021/la901565q · Cited by 59
Alakhov, V. Y., Pietrzyński, G., Patel, K., Kabanov, A. V., Bromberg, L. E., & Hatton, T. A. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357044427 · Cited by 57
Shen, J., Carcaboso, A. M., Hubbard, K. E., Tagen, M., Wynn, H. G., Panetta, J. C., Waters, C. M., Elmeliegy, M. A., & Stewart, C. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0700 · Cited by 57
Alcaro, S., Ventura, C. A., Paolino, D., et al. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00217-2 · Cited by 56
Studies on the human pharmacokinetics of isophosphamide (NSC-109724).
Lm, A., Creaven, P. J., & Rl, N. (1976) · PubMed · Cited by 53
Cavallaro, G., Maniscalco, L., Licciardi, M., & Giammona, G. (2004) · Macromolecular Bioscience · doi:10.1002/mabi.200400089 · Cited by 53
Lee, R. W., Shenoy, D. B., & Sheel, R. (2009) · Elsevier eBooks · doi:10.1016/b978-0-8155-2025-2.10002-2 · Cited by 52
Li, X., & Choi, J. (2009) · PubMed · Cited by 51
Ge, W., Li, Y., Li, Z., Zhang, S., Sun, Y., Hu, P., Wang, X., Huang, Y., Si, S., Zhang, X., et al. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0539-9 · Cited by 50
Substrate-dependent modulation of the catalytic activity of CYP3A by erlotinib
Dong, P., Fang, Z., Zhang, Y., Ge, G., Mao, Y., Zhu, L., Qu, Y.-Q., Li, W., Wang, L., Liu, C., et al. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.218 · Cited by 50
Qhattal, H. S. S., Wang, S. F., Salihima, T., Srivastava, S., & Liu, X. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf202612b · Cited by 50
Yen, W.-C., & Lamph, W. W. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0018 · Cited by 48
Design and in vitro evaluation of a novel polymeric P-glycoprotein (P-gp) inhibitor
Iqbal, J., Hombach, J., Matuszczak, B., et al. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.06.023 · Cited by 45
Fayad, W., Rickardson, L., Haglund, C., Olofsson, M. H., D’Arcy, P., Larsson, R. L., Linder, S. T., & Fryknäs, M. (2011) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2011.01170.x · Cited by 45
Lee, T.-B., Park, J.-H., Min, Y., Kim, K.-J., & Choi, C.-H. (2008) · BMC Gastroenterology · doi:10.1186/1471-230x-8-33 · Cited by 45
Controlled Release of Methotrexate from W/O Microemulsion and Its In Vitro Antitumor Activity
Karasulu, H. Y., Karabulut, B., Göker, E., Güneri, T., & Gabor, F. (2007) · Drug Delivery · doi:10.1080/10717540601067760 · Cited by 45
Oral Bioavailability: Basic Principles, Advanced Concepts, and Applications
Hu, M., & Xiao-ling, L. (2011) · Cited by 45
Development of microemulsion of mitotane for improvement of oral bioavailability
Attivi, D., Ajana, I., Astier, A., et al. (2010) · Drug Development and Industrial Pharmacy · doi:10.3109/03639040903225083 · Cited by 44
Upadhyay, A. K., Singh, S., Chhipa, R. R., Vijayakumar, M. V., Ajay, A. K., & Bhat, M. K. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.05.009 · Cited by 43
Experimental chemotherapy of human medulloblastoma with classical alkylators.
Hs, F., Colvin, O. M., LUDEMAN, S. M., Schold, S. C., Boyd, V. L., Lh, M., & Bigner, D. D. (1986) · PubMed · Cited by 41
Gong, X., Moghaddam, M. J., Sagnella, S. M., Conn, C. E., Danon, S. J., Waddington, L. J., & Drummond, C. J. (2011) · ACS Applied Materials & Interfaces · doi:10.1021/am200117u · Cited by 41
Wirth, M., Kneuer, C., Lehr, C., & Gabor, F. (2002) · Journal of drug targeting · doi:10.1080/1061186021000038300 · Cited by 38
Lack of Association Between Excretion of Sorafenib in Sweat and Hand‐Foot Skin Reaction
Jain, L., Gardner, E. R., Figg, W. D., Chernick, M. S., & Kong, H. H. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.1.52 · Cited by 38
A novel micelle-encapsulated platinum(II) anticancer agent
Jadhav, V. B., Jun, Y. J., Song, J. H., Park, M. K., Oh, J. H., Chae, S. W., Kim, I.-S., Choi, S.-J., Lee, H. J., & Sohn, Y. S. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.07.101 · Cited by 36
Drug Delivery in Cancer Using Liposomes
Dass, C. R. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-210-6_9 · Cited by 35
Hafny‐Rahbi, B. E., Cano, N. J., Pidotti, M., Régina, A., Scherrmann, J., & Roux, F. S. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00093-2 · Cited by 34
The effect of polyoxyethylene polymers on the transport of ranitidine in Caco-2 cell monolayers
Ashiru-Oredope, D. A. I., Patel, N., Forbes, B., Patel, R., & Basit, A. W. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.02.059 · Cited by 33
Greindl, M., Föger, F., Hombach, J., & Bernkop‐Schnürch, A. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.03.008 · Cited by 33
Rajpoot, P., Bali, V., & Pathak, K. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.01.027 · Cited by 33
Wang, J., Qu, H. Y., Jin, L., Zeng, W., Qin, L., Zhang, F., Wei, X., Lü, W.-L., Zhang, C., & Liang, W. P. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22461 · Cited by 30
Goemans, B. F. (2005) · Blood · doi:10.1182/blood-2005-04-1640 · Cited by 26
Gefitinib accumulation in glioblastoma tissue
Höfer, S., Frei, K., & Rutz, H. P. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.5.2653 · Cited by 25
Breast cancer patients preferences for oral versus intravenous second-line anticancer therapy
Wojtacki, J., Wiraszka, R., Rolka-Stempniewicz, G., & Grzegorczyk, M. (2006) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(06)80401-5 · Cited by 24
Lymphatic Biodistribution of Polylactide Nanoparticles
Chaney, E. J., Tang, L., Tong, R., Cheng, J., & Boppart, S. A. (2010) · Molecular Imaging · doi:10.2310/7290.2010.00012 · Cited by 23
Rocha, M. P., Fdez‐Riverola, F., Shatkay, H., & Corchado, J. M. (2010) · Advances in intelligent and soft computing · doi:10.1007/978-3-642-13214-8 · Cited by 21
Singh, B. N. (2015) · Taylor & Francis eBooks · doi:10.1081/e-ebpp-120050250 · Cited by 21
Bhardwaj, V., Plumb, J. A., Cassidy, J., & Kumar, M. N. V. R. (2010) · Cancer Nanotechnology · doi:10.1007/s12645-010-0004-2 · Cited by 12
Shibayama, Y., Takeda, Y., & Yamada, K. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.493 · Cited by 10
Ethirajulu, K., & Jayaram, R. (2011) · InTech eBooks · doi:10.5772/27799 · Cited by 8
Cardiovascular drug interactions with tyrosine kinase inhibitors
(2010) · Cardiovascular Medicine · doi:10.4414/cvm.2010.01503 · Cited by 7
ABC Transporters in Intestinal and Liver Efflux
Morris, M. E., & Gandhi, Y. (2011) · Wiley eBooks · doi:10.1002/9781118067598.ch24 · Cited by 1
Cited by
New developments in liposomal drug delivery
Pattni, B. S., Chupin, V. V., & Torchilin, V. P. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00046 · Cited by 1,600
Chandrakala, V., Aruna, V., & Angajala, G. (2022) · Emergent Materials · doi:10.1007/s42247-021-00335-x · Cited by 768
Bilia, A. R., Guccione, C., Isacchi, B., Righeschi, C., Firenzuoli, F., & Bergonzi, M. C. (2014) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2014/651593 · Cited by 514
RetractedHydrogel-Based Controlled Drug Delivery for Cancer Treatment: A Review
Sun, Z., Song, C., Wang, C., Hu, Y., & Wu, J. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01020 · Cited by 413
Nanotechnology Approaches for Increasing Nutrient Bioavailability
Jafari, S. M., & McClements, D. J. (2017) · Advances in Food and Nutrition Research · doi:10.1016/bs.afnr.2016.12.008 · Cited by 386
Metadata
- Authors
- Thanki, K., Gangwal, R. P., Sangamwar, A. T., & Jain, S.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 170
- Issue
- 1
- Pages
- 15-40
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2003987803
- Cited by
- 499
- References
- 295
- FWCI
- 23.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.